COVID-19
Blood cancer patients who have been double-vaccinated against COVID-19 are still left vulnerable to the virus, with more than half unable to mount an antibody response to SARS-CoV-2, researchers have found. The study, which was published in a letter to Cancer Cell, examined the immune protection offered by delayed Pfizer
Pharmaceutical industry
The global oncology clinical trials market is experiencing significant growth, driven by the increasing burden of cancer worldwide, the growing role of precision and personalized medicine for cancer treatment, and the presence of big outsourcing firms in the region. According to a recent report by ResearchAndMarkets.com, the market is
Pharmaceutical industry
The Allegheny Health Network has initiated a comprehensive COVID-19 vaccination campaign for children between the ages of 5 and 11, following the emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine series by the FDA and CDC. The network has released vaccine appointment slots for families and begun administering the
Pharmaceutical industry
The Biden administration has announced new vaccine rules for private businesses with 100 or more employees, certain healthcare workers, and federal contractors. The rules, set to take effect on January 4, require employees in these groups to receive two doses of Pfizer or Moderna's vaccine or one dose
COVID-19
The United States has entered a new phase in its COVID-19 vaccination campaign, with shots now available to millions of elementary-age children. This development comes after more than 18 months of illness, hospitalizations, and deaths, as well as disrupted education. With the federal government promising enough vaccine to protect the
COVID-19
Experts are weighing the benefits and risks of vaccinating all children in this age group, considering the potential impact of COVID-19 on kids and the effectiveness of the vaccine. The Center for Disease Control and Prevention (CDC) must sign off before widespread vaccinations can begin. Doctors who have cared for
Pharmaceutical industry
A significant milestone in the fight against COVID-19 has been reached, as the Food and Drug Administration's panel of independent advisors has recommended emergency use authorization for the Pfizer-BioNTech vaccine in children aged 5 to 11. This decision, pending formal approval from the FDA, would allow for widespread
COVID-19
The global osteoarthritis therapeutics market reached a value of nearly US$8 Billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.4% during 2021-2026. The market is driven by factors such as the growing geriatric population, sedentary lifestyles, and unhealthy dietary patterns,
Pharmaceutical industry
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have announced the expansion of COVID-19 vaccine booster doses, allowing for a mix-and-match strategy. CDC Director Rochelle Walensky, M.D., has endorsed recommendations from the Advisory Committee on Immunization Practices (ACIP) for the use of
Pharmaceutical industry
The pharmaceutical industry's powerful trade group, Pharmaceutical Research and Manufacturers of America (PhRMA), has launched a wide-ranging campaign to kill Democrats' sweeping drug price proposal, a crucial tool to reduce high drug prices. For months, PhRMA has spent millions on lobbying and TV ads warning that the
COVID-19
Major pharmacies in the US have begun offering COVID-19 booster shots, with the latest guidance from the US health officials allowing for the extra dose for Moderna and Johnson & Johnson vaccines. The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have signed off
COVID-19
Walmart and Sam's Club pharmacies are now ready to administer booster shots for Moderna and Johnson & Johnson (J&J) COVID-19 vaccines, following the Centers for Disease Control and Prevention's (CDC) authorization. This development comes after Pfizer's COVID-19 vaccine became eligible as a
